No recent acquisitions found related to Prospect Venture Partners
Prospect Venture Partners Funding History
No recent funding data found related to Prospect Venture Partners
Prospect Venture Partners Investments
SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.
Sep 21, 2016
Aug 01, 2019
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
Oct 08, 2014
Apr 03, 2019
Nora develops therapeutics to address unmet clinical needs in reproductive medicine.
Apr 16, 2014
Element Science develops a wearable therapeutic device that detects and treats arrhythmias.
Mar 04, 2014
NinePoint Medical designs and develops Optical Coherence Tomography imaging systems for the evaluation of human tissue microstructure.
Mar 02, 2014
These are all the companies that Prospect Venture Partners has invested in. Prospect Venture Partners has invested 29 companies and its latest investment was SentreHEART in Sep 21,. SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.
Prospect Venture Partners is a venture capital firm that focuses on investing in outstanding biopharmaceutical and medical device companies. Prospect Venture Partners was founded in 06/1997. Prospect Venture Partners' headquarters is located in Palo ...